Search results for "Particle"
showing 10 items of 15225 documents
"Table 29" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …
2017
p/$\phi$ ratio as a function of $p_{\rm T}$ for inelastic (INEL) pp collisions at $\sqrt{s}=2.76~{\rm TeV}$.
"Table 19" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …
2017
$\phi$/K ratio as a function of $p_{\rm T}$ for inelastic (INEL) pp collisions at $\sqrt{s}=2.76~{\rm TeV}$.
"Table 23" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …
2017
$\phi$/$\pi$ ratio as a function of $p_{\rm T}$ for inelastic (INEL) pp collisions at $\sqrt{s}=2.76~{\rm TeV}$.
"Table 18" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …
2017
$\phi$/K ratio as a function of $p_{\rm T}$ for 0-5$\%$ centrality in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76~{\rm TeV}$.
"Table 27" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …
2017
p/$\phi$ ratio as a function of $p_{\rm T}$ for 0-5$\%$ centrality in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76~{\rm TeV}$.
"Table 22" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …
2017
$\phi$/$\pi$ ratio as a function of $p_{\rm T}$ for 0-5$\%$ centrality in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76~{\rm TeV}$
"Table 28" of "K$^{*}(892)^{0}$ and $\phi(1020)$ meson production at high transverse momentum in pp and Pb-Pb collisions at $\sqrt{s_\mathrm{NN}}$ = …
2017
p/$\phi$ ratio as a function of $p_{\rm T}$ for 60-80$\%$ centrality in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76~{\rm TeV}$.
PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions
2015
Nanocarriers of amphiphilic polymeric materials represent versatile delivery systems for poorly water soluble drugs. In this work the technique of solvent evaporation from multiple emulsions was applied to produce nanovectors based on new amphiphilic copolymer, the α,β-poly(N-2-hydroxyethyl)-DL-aspartamide-polylactic acid (PHEA-PLA), purposely synthesized to be used in the controlled release of active molecules poorly soluble in water. To this aim an amphiphilic derivative of PHEA, a hydrophilic polymer, was synthesized by derivatization of the polymeric backbone with hydrophobic grafts of polylactic acid (PLA). The achieved copolymer was thus used to produce nanoparticles loaded with α toc…
Spray dried hyaluronic acid microparticles for adhesion controlled aggregation and potential stimulation of stem cells
2017
Spray-dried microparticles of a derivative of hyaluronic acid (HA) have been engineered to obtain a controlled aggregation with Human Mesenchymal Stem Cells (hMSCs) into 3D constructs. We demonstrated the utility of chemical functionalization of a native constituent of the extracellular matrix to improve processing performances and to control on stem cell adhesion and differentiation. Native hyaluronic acid (HA), cell adhesive peptides (RGD), transforming growth factor β3, dexamethasone are biological agents potentially suitable for chondrogenic stimulation of hMSCS. However unmodified HA suffers of drawbacks in terms of stability and versatility of processing. Functionalization strategies…
Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation.
2017
Abstract In this paper, we describe the preparation of polymeric nanoparticles (NPs) loaded with sorafenib for the treatment of hepatocellular carcinoma (HCC). A synthetic brush copolymer, named PHEA-BIB-ButMA (PBB), was synthesized by Atom Trasnfer Radical Polymerization (ATRP) starting from the α-poly( N -2-hydroxyethyl)- d , l -aspartamide (PHEA) and poly butyl methacrylate (ButMA). Empty and sorafenib loaded PBB NPs were, then, produced by using a dialysis method and showed spherical morphology, colloidal size, negative ζ potential and the ability to allow a sustained sorafenib release in physiological environment. Sorafenib loaded PBB NPs were tested in vitro on HCC cells in order to e…